Red Bull Mobile Esports Open Season 3 returns with exciting mobile games

Red Bull Mobile Esports Open is back for Season 3 With over 15,000 participants during last season Top games from the world’s leading video game publishers Now featuring PUBG MOBILE, Hearthstone and Teamfight Tactics Mobile Online Qualifiers are hosted by official partner tournament center Open to all – won by one. The Red Bull Mobile Read more about Red Bull Mobile Esports Open Season 3 returns with exciting mobile games[…]

Seat. And space. »LONELY RIDER« adventure package

Seat. And space. »LONELY RIDER« adventure package. Only available in 2020 and as part of EDITION 35 Experience has shown that enduro riders who have traveled on intercontinental or even world tours rely on a seat that is comfortable and active in every respect and use the rest of the large travel enduro to fit Read more about Seat. And space. »LONELY RIDER« adventure package[…]

ENHERTU® Significantly Improved Tumor Response Rate and Overall Survival in HER2 Positive Metastatic Gastric Cancer in Pivotal Phase 2 DESTINY-Gastric01 Trial

First HER2 directed therapy to show an improvement in overall survival for previously-treated metastatic gastric cancer with a 41% reduction in the risk of death versus chemotherapy Breakthrough Therapy Designation recently granted in the U.S. for ENHERTU in this setting Detailed results from the positive pivotal randomized, controlled phase 2 DESTINY-Gastric01 trial showed Daiichi Sankyo Read more about ENHERTU® Significantly Improved Tumor Response Rate and Overall Survival in HER2 Positive Metastatic Gastric Cancer in Pivotal Phase 2 DESTINY-Gastric01 Trial[…]

ENHERTU® Achieved a Tumor Response Rate of 45.3% in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial

Results from the phase 2 DESTINY-CRC01  trial of Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s ENHERTU®     (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningful activity in patients with HER2 positive unresectable and/or metastatic colorectal cancer who received at least two prior lines of standard treatment. These results were presented today at the 2020 American Society of Clinical Read more about ENHERTU® Achieved a Tumor Response Rate of 45.3% in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial[…]

ENHERTU® Demonstrated Meaningful Clinical Activity in Patients with HER2 Mutant Non-Small Cell Lung Cancer in Interim Analysis of Phase 2 DESTINY-Lung01 Trial

9% of patients with HER2 mutant metastatic non-small cell lung cancer treated with ENHERTU achieved a tumor response Breakthrough Therapy Designation recently granted in the U.S. in this setting Results from the ongoing phase 2 DESTINY-Lung01 trial showed Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) achieved a clinically meaningful tumor Read more about ENHERTU® Demonstrated Meaningful Clinical Activity in Patients with HER2 Mutant Non-Small Cell Lung Cancer in Interim Analysis of Phase 2 DESTINY-Lung01 Trial[…]

SysOZ EDB to PST Converter Software

SysOZ software, the leading solution for producing complex products and integrated software, today announced the release of EDB converter. This new EDB converter will simplify and ease the EDB conversion process. MS Outlook is a very famous email client that can allow it to have the various features to the users. EDB files are offline Read more about SysOZ EDB to PST Converter Software[…]

Indorama Ventures PCL sets up special fund to support local projects

Thailand concern Indorama Ventures PCL (IVL), Trevira’s parent company, has pledged to provide financial support to selected charities during the Covid-19 pandemic through a special appeal fund. The money is to be allocated to local projects helping people and organisations facing especial hardship due to the coronavirus crisis. During this challenging time, Indorama wants to Read more about Indorama Ventures PCL sets up special fund to support local projects[…]

Innovation and Resiliency Drive Dell Technologies‘ First Quarter Fiscal 2021 Financial Results

Dell Technologies effectively navigates COVID-19 environment with innovative products, broad capabilities, flexible supply chain and resilient global workforce First quarter revenue of $21.9 billion Operating income up 28% to $702 million, non-GAAP operating income of $2.2 billion Client Solutions Group revenue up 2% to $11.1 billion; VMware revenue up 12% Dell Technologies (NYSE: DELL) announces financial results for its fiscal 2021 first quarter. First quarter Read more about Innovation and Resiliency Drive Dell Technologies‘ First Quarter Fiscal 2021 Financial Results[…]

stackconf online: full schedule now available

The organizer NETWAYS Event Services announces the schedule for the conference stackconf online. The open source infrastructure event focuses on topics in the fields of hybrid cloud technologies, containers, and agile methods and continuous integration. stackconf online takes place June 16 to 18, 2020. The complete agenda for stackconf 2020 is now available. At the beginning Read more about stackconf online: full schedule now available[…]

Point clouds for better construction in existing buildings: ALLPLAN cooperates with laser scanning specialist Scalypso

ALLPLAN, an international provider of open BIM solutions, has entered into a partnership with laser scanning specialist Scalypso in order to make point cloud based working accessible to a wide range of users in a simple and practical form. As part of the cooperation, a plug-in was developed which is available in the current Allplan Read more about Point clouds for better construction in existing buildings: ALLPLAN cooperates with laser scanning specialist Scalypso[…]